|
Sign In to gain access to subscriptions and/or personal tools.
|
Uncertainty in Decision Models Analyzing Cost-Effectiveness
The Joint Distribution of Incremental Costs and Effectiveness Evaluated with a Nonparametric Bootstrap Method
Maria G.M. Hunink
Jan Roelf Bult
Jelle De Vries
Milton C. Weinstein
Purpose. To illustrate the use of a nonparametric bootstrap method in the evaluation of uncertainty in decision models analyzing cost-effectiveness. Methods. The authors reevaluated a previously published cost-effectiveness analysis that used a Markov model comparing initial percutaneous transluminal angioplasty with bypass surgery for femoropopliteal lesions. Each probability in the model was simulated with a first-order Monte Carlo simulation to represent sampling uncertainty. Superimposed on this, a second-order Monte Carlo simulation was performed to represent parameter uncer tainty, drawing the probability values from nonparametric distributions based on published data or from primary collected data as available. After simulation of a mixed (i.e., non-idenfical) cohort of 30,000 patients, 3,000 bootstrap samples of 1,000 pa tients each were drawn and the joint distribution of mean incremental costs and mean effectiveness gained was evaluated. Results. Using a bootstrap sample size of 1,000 patients, 92.7% of the joint distribution of mean incremental costs and mean effective ness gained fell in the quadrant where angioplasty dominated bypass surgery. Another 6.9% of samples demonstrated either greater effectiveness with an incremental cost- effectiveness ratio of at most $20,000/QALY gained, or cost savings with a ratio of at least $20,000 saved/QALY lost. Conclusion. A nonparametric bootstrap method can be used to estimate the joint distribution of mean incremental costs and mean effec tiveness gained, and the results can provide an understanding of the uncertainty in a cost-effectiveness analysis based on a decision model. Key words: cost-effective ness analysis; sensitivity analysis; Monte Carlo simulation; Markov models; bootstrap ping. (Med Decis Making 1998;18:337-346)
Medical Decision Making, Vol. 18, No. 3,
337-346 (1998)
DOI: 10.1177/0272989X9801800312
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. M. Hovels, R. A. M. Heesakkers, E. M. M. Adang, J. O. Barentsz, G. J. Jager, and J. L. Severens
Cost-effectiveness of MR Lymphography for the Detection of Lymph Node Metastases in Patients with Prostate Cancer
Radiology,
September 1, 2009;
252(3):
729 - 736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Cohen and M. R. Reynolds
Interpreting the results of cost-effectiveness studies.
J. Am. Coll. Cardiol.,
December 16, 2008;
52(25):
2119 - 2126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N J Bansback, A Brennan, and O Ghatnekar
Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden
Ann Rheum Dis,
July 1, 2005;
64(7):
995 - 1002.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rinfret, D. J. Cohen, G. A. Lamas, K. E. Fleischmann, M. C. Weinstein, J. Orav, E. Schron, K. L. Lee, and L. Goldman
Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction
Circulation,
January 18, 2005;
111(2):
165 - 172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Rost, J. M. Pyne, L. M. Dickinson, and A. T. LoSasso
Cost-Effectiveness of Enhancing Primary Care Depression Management on an Ongoing Basis
Ann. Fam. Med,
January 1, 2005;
3(1):
7 - 14.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Stevenson, J. Oakley, and J. B. Chilcott
Gaussian Process Modeling in Conjunction with Individual Patient Simulation Modeling: A Case Study Describing the Calculation of Cost-Effectiveness Ratios for the Treatment of Established Osteoporosis
Med Decis Making,
January 1, 2004;
24(1):
89 - 100.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Bakhai, G. W. Stone, C. L. Grines, S. A. Murphy, L. Githiora, R. H. Berezin, D. A. Cox, T. Stuckey, J. J. Griffin, J. E. Tcheng, et al.
Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction: Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial
Circulation,
December 9, 2003;
108(23):
2857 - 2863.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. N. Venditti, C. P. Venditti, G. T. Berry, P. B. Kaplan, E. M. Kaye, H. Glick, and C. A. Stanley
Newborn Screening by Tandem Mass Spectrometry for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cost-Effectiveness Analysis
Pediatrics,
November 1, 2003;
112(5):
1005 - 1015.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Gould, G. D. Sanders, P. G. Barnett, C. E. Rydzak, C. C. Maclean, M. B. McClellan, and D. K. Owens
Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules
Ann Intern Med,
May 6, 2003;
138(9):
724 - 735.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Mandelblatt, W. F. Lawrence, L. Gaffikin, K. K. Limpahayom, P. Lumbiganon, S. Warakamin, J. King, B. Yi, P. Ringers, and P. D. Blumenthal
Costs and Benefits of Different Strategies to Screen for Cervical Cancer in Less-Developed Countries
J Natl Cancer Inst,
October 2, 2002;
94(19):
1469 - 1483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Mandelblatt, W. F. Lawrence, S. M. Womack, D. Jacobson, B. Yi, Y.-t. Hwang, K. Gold, J. Barter, and K. Shah
Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
JAMA,
May 8, 2002;
287(18):
2372 - 2381.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. F. Halpern, M. C. Weinstein, M. G.M. Hunink, and G. S. Gazelle
Representing Both First- and Second-order Uncertainties by Monte Carlo Simulation for Groups of Patients
Med Decis Making,
July 1, 2000;
20(3):
314 - 322.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. A. Craig, M. A. Black, and P. P. Sendi
Uncertainty in Decision Models Analyzing Cost-Effectiveness
Med Decis Making,
January 1, 2000;
20(1):
135 - 136.
[PDF]
|
|
|
|
|
|
|
M. G.M. Hunink, A. A. Stinnett, T. Stijnen, and M. C. Weinstein
Letter
Med Decis Making,
January 1, 2000;
20(1):
136 - 137.
[PDF]
|
|
|
|
|
|
|
P. P. Sendi, B. A. Craig, G. Meier, D. Pfluger, A. Gafni, M. Opravil, M. Battegay, and H. C. Bucher
Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy
J. Antimicrob. Chemother.,
December 1, 1999;
44(6):
811 - 817.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Chessa, R. Dekker, B. Van Vliet, E. W. Steyerberg, and J. D. F. Habbema
Correlations in Uncertainty Analysis for Medical Decision Making: An Application to Heart-valve Replacement
Med Decis Making,
August 1, 1999;
19(3):
276 - 286.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. A. Stinnett
Is It Really So Bad to be Unambiguously Ineificient?: The Role of Dominance in Stochastic Cost--Effectiveness Analysis
Med Decis Making,
January 1, 1999;
19(1):
102 - 103.
[PDF]
|
|
|
|
|
